Olmutinib (BI 1482694) ADME Study
Clinical trial NCT02722161 · COMPLETED
Trial details
- NCT number
- NCT02722161
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2016-06-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.